Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. It develops several patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases, and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The company was founded on June 14, 2021 and is headquartered in Calgary, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Marvel Biosciences Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Marvel Biosciences Corp market cap is $9.48M.
What is the 52-week high for Marvel Biosciences Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Marvel Biosciences Corp 52 week high is $0.241 as of September 06, 2025.
What is the 52-week low for Marvel Biosciences Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Marvel Biosciences Corp 52 week low is $0.046 as of September 06, 2025.
What is Marvel Biosciences Corp stock price today?
Marvel Biosciences Corp stock price today is $0.1828.
What was Marvel Biosciences Corp stock price yesterday?
Marvel Biosciences Corp stock price yesterday was $0.179.
What is the PE ratio of Marvel Biosciences Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Marvel Biosciences Corp’s P/E ratio is -6.96.
What is the Price-to-Book ratio of Marvel Biosciences Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Marvel Biosciences Corp P/B ratio is -4.4111.
What is the 50-day moving average of Marvel Biosciences Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Marvel Biosciences Corp 50-day moving average is $0.134.
